J. Ong

729 total citations
19 papers, 492 citations indexed

About

J. Ong is a scholar working on Surgery, Hematology and Molecular Biology. According to data from OpenAlex, J. Ong has authored 19 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in J. Ong's work include Testicular diseases and treatments (16 papers), Multiple Myeloma Research and Treatments (5 papers) and Neuroblastoma Research and Treatments (4 papers). J. Ong is often cited by papers focused on Testicular diseases and treatments (16 papers), Multiple Myeloma Research and Treatments (5 papers) and Neuroblastoma Research and Treatments (4 papers). J. Ong collaborates with scholars based in United Kingdom, Denmark and United States. J. Ong's co-authors include R.T.D. Oliver, C. Gallagher, M.V. Williams, Marek Ostrowski, M.A. Raja, R. Timothy D. Oliver, Chris Boshoff, Jonathan Shamash, Gordon Rustin and R. Ravi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

J. Ong

17 papers receiving 479 citations

Peers

J. Ong

SURGE

RHEUM

PRM

NEURO

Fulvio Zanoni Italy

R. Bastús Spain

Tobias Pottek Germany

J.R. Spermon Netherlands

H. Yosef United Kingdom

SD Fosså Norway

Ralf Witthuhn Germany

J.P. Droz France

A. Greist United States

Jean-Pierre Lotz France

Fulvio Zanoni Italy

J. Ong

430 ×1.0

SURGE

143 ×1.0

RHEUM

145 ×1.0

PRM

100 ×0.7

NEURO

140 ×1.0

Citations per year, relative to J. Ong J. Ong (= 1×) peers Fulvio Zanoni

Countries citing papers authored by J. Ong

Since Specialization

Citations

This map shows the geographic impact of J. Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ong more than expected).

Fields of papers citing papers by J. Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ong. The network helps show where J. Ong may publish in the future.

Co-authorship network of co-authors of J. Ong

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ong. A scholar is included among the top collaborators of J. Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ong. J. Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ong, J., et al.. (2021). Use of hydrocolloid protective sheets to protect skin against direct contact from body secretions. 41(4).

Williams, M.V., David E. Neal, J. Ong, et al.. (2008). Stage migration and pilot studies of reduced chemotherapy supported by positron‐emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour. British Journal of Urology. 101(5). 570–574. 1 indexed citations

Oliver, R.T.D., J. Ong, Jonathan Shamash, et al.. (2004). long-term follow-up of anglian germ cell cancer group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy. Urology. 63(3). 556–561. 67 indexed citations

Powles, Tom, Mark Bower, Jonathan Shamash, et al.. (2004). Outcome of patients with HIV-related germ cell tumours: a case–control study. British Journal of Cancer. 90(8). 1526–1530. 20 indexed citations

Powles, Thomas, Jonathan Shamash, J. Ong, et al.. (2004). The rising incidence of stage 1 seminoma; a reflection of earlier diagnosis of germ cell cancer of the testis in last 20 years. Journal of Clinical Oncology. 22(14_suppl). 4521–4521.

Oliver, R.T.D., et al.. (2003). Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma‐in‐situ. Apmis. 111(1). 86–92. 11 indexed citations

Shamash, Jonathan, et al.. (2001). Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study. Cancer Chemotherapy and Pharmacology. 47(4). 370–372. 2 indexed citations

Shamash, Jonathan, R.T.D. Oliver, J. Ong, et al.. (1999). Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy. Annals of Oncology. 10(6). 685–692. 20 indexed citations

Ravi, R., J. Ong, R.T.D. Oliver, et al.. (1999). Surgery as Salvage Therapy in Chemotherapy-Resistant Nonseminomatous Germ Cell Tumours. The Journal of Urology. 161(3). 1026–1026. 4 indexed citations

10.

Ravi, R., R.T.D. Oliver, J. Ong, et al.. (1997). A single‐centre observational study of surgery and late malignant events after chemotherapy for germ cell cancer. British Journal of Urology. 80(4). 647–652. 28 indexed citations

11.

Oliver, R.T.D., J. Ong, J. P. BLANDY, & D G Altman. (1996). Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978–1994. British Journal of Urology. 78(1). 119–124. 26 indexed citations

12.

Boshoff, Chris, Richard H. J. Beǵent, R.T.D. Oliver, et al.. (1995). Secondary tumours following etoposide containing therapy for germ cell cancer. Annals of Oncology. 6(1). 35–40. 88 indexed citations

13.

Boshoff, C., R.T.D. Oliver, C. Gallagher, & J. Ong. (1995). Accelerated cisplatin-based chemotherapy for advanced bladder cancer. European Journal of Cancer. 31(10). 1633–1636. 6 indexed citations

14.

Oliver, R.T.D., Michael Leahy, & J. Ong. (1995). Combined seminoma/non-seminoma should be considered as intermediate grade germ cell cancer (GCC). European Journal of Cancer. 31(9). 1392–1394. 5 indexed citations

15.

Oliver, R.T.D., Polly Edmonds, J. Ong, et al.. (1994). Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?. International Journal of Radiation Oncology*Biology*Physics. 29(1). 3–8. 98 indexed citations

16.

Oliver, R.T.D., M.A. Raja, J. Ong, & C. Gallagher. (1992). Pilot Study to Evaluate Impact of a Policy of Adjuvant Chemotherapy for High Risk Stage 1 Malignant Teratoma on Overall Relapse Rate of Stage 1 Cancer Patients. The Journal of Urology. 148(5 Part 1). 1453–1455. 59 indexed citations

17.

Krupp, P., R.T.D. Oliver, J. Ong, et al.. (1991). Secondary pre-leukaemia and etoposide. The Lancet. 338(8777). 1269–1270. 10 indexed citations

18.

Oliver, R. Timothy D., et al.. (1990). Alternatives to Radiotherapy in the Management of Seminoma. British Journal of Urology. 65(1). 61–67. 37 indexed citations

19.

Jones, Giffin D., J. Ray Runyon, & J. Ong. (1961). Isobutylene copolymers of vinylbenzyl chloride and isopropenylbenzyl chloride. Journal of Applied Polymer Science. 5(16). 452–459. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact